Brief: Mink Therapeutics Reports Q1 Loss Per Share Of $0.23
10/05/2022 13:11
May 10 (Reuters) - Mink Therapeutics Inc INKT.O :
* Q1 LOSS PER SHARE $0.23
* PER SHARE LOSSES WERE $0.23 IN Q1 OF 2022
* ENDED Q1 2022 WITH A CASH BALANCE OF $34.7 MILLION AS
COMPARED
TO $38.9 MILLION AT DECEMBER 31, 2021
Source text for Eikon: ID:nGNX3RrtFb
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's